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ABSTRACT:
Bckground: In this report authors discuss similarities between psychiatric phenomenon i.e. catatonia and
neuropsychiatric syndromes such as progressive supranuclear palsy (PSP) in a 51 years old male, known case of
hypertension and diabetes, who presented to the psychiatric services with mutism, stereotypical movements of upper
limbs, echolalia, anteriorly flexed neck, swallowing difficulty, decreased oral intake, urinary and fecal incontinence for
a period of 1 year worsened for 6 months. Patient was initially treated for catatonia with benzodiazepines and
electroconvulsive therapy but did not improve. A neuropsychiatric consultation was sought and a diagnosis of possible
PSP was made according to the National Institute of Neurological Disorders and Stroke and Society for PSP
(NINDS-SPSP ) criteria.
The authors discuss the importance of considering other differential diagnoses such as PSP in patients who present
with symptoms that may resemble catatonia and psychiatric syndromes.

INTRODUCTION: Catatonia is a clinical syndrome
characterized by motoric immobility or excitement,
profound negativism, echolalia (mimicry of speech) or
echopraxia (mimicry of movement).1 It may occur
secondary to a general medical condition, as a result of
primary psychiatric disorder such as schizophrenia or
psychotic depression or during the course of delirium.
Benzodiazepines and electroconvulsive therapy are the
mainstay treatment of catatonia.2

cognitive or behavioral presentations (PSP-F), including
behavioral variant frontotemporal dementia (bvFTD),
progressive gait freezing (PSPPGF), corticobasal
syndrome (PSP-CBS), primary lateral sclerosis
(PSPPLS),
cerebellar
ataxia
(PSP-C),
and
speech/language disorders (PSP-SL), including
nonfluent/agrammatic primary progressive aphasia
(nfaPPA) and progressive apraxia of speech (AOS).4
Due to the complicated presentations, low sensitivity of
the diagnostic criterion and symptom overlap with
some psychiatric conditions, the diagnosis is difficult to
make at the first clinical visit and the mean duration is
3-4 years after the onset of first symptoms.5

Progressive supranuclear palsy is a rare and progressive
neurodegenerative condition with vertical supranuclear
gaze palsy plus postural instability and falls within the
first year of symptom onset to diagnose “probable” PSP,
and the presence of either supranuclear gaze palsy or a
combination of slow vertical saccades and postural
instability with falls within the first year to diagnose
“possible”
PSP.3
However
patients
with
autopsy-confirmed PSP have been reported with variant
PSP
clinical
presentations,
including
initial
predominance of ocular motor dysfunction (PSP-OM),
postural instability (PSP-PI), Parkinsonism resembling
idiopathic Parkinson’s disease (PSP-P), frontal lobe
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CASE REPORT:
Mr. A, 51 years old male presented with memory
problems for the last four years. This was followed by
anxiety like symptoms, which included breathlessness,
preference to sleep in open places, irritability and
slurred speech. He also exhibited confusional states
such as getting intimately close to other males who
were strangers. He later developed difficulty in
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swallowing which was gradual. Gait changes were also
reported by the family, which started 6 months prior to
his presentation and was described as shuffling with
small steps.
He had become completely dependent on family for
activities of daily living and also developed double
incontinence. Features of dysautonomia such as
incontinence and dysphagia were not present from the
beginning in the course of the disease. This was elicited
on history; autonomic testing was not done. Speech
became scanty with element of echolalia.
Due to vague symptoms and complex presentation, he
was referred to neurology to rule out any organic cause.
Apart from brisk reflexes in lower limb, neurological
examination was reported to be unremarkable and a
working diagnosis of catatonia was made. Differential
diagnoses
included
schizophrenia,
dementia,
Parkinson’s disease and organic/neurological disorder.
On mental state examination he appeared to have an
expressionless face with reduced blinking. No rest
tremor was noted. Speech was slurred, with reduced
output and echolalia was observed. Affect was
restricted and flat. The following day, patient became
mute and more perplexed and stopped following
instructions. He maintained stooped postures and at
other times used to pace. The psychiatry team was the
primary team and started treatment of catatonia with
oral lorazepam up to 12 mg per 24 hours in 6 divided
doses. This was continued for 4 days. However, no
improvement was observed and patient started
developing increasing drowsiness and so lorazepam
was reduced to 10 mg per day and Carbamazepine 50
mg twice a day was started which was later titrated to
100 mg twice a day. Other medications during the
course of the disease included Sertraline and
Quetiapine, which were stopped at the time of his
admission. He was on them intermittently for last 6
months.
MRI of head and neck were carried out to look for any
other causes of patients’ symptoms.
Brain MRI showed mild diffuse cortical atrophy and mild
periventricular and subcortical deep white matter
ischemic changes. MRI neck showed multilevel disc
osteophyte complexes with facet arthropathy with no
signal abnormality in the cord. Psychiatry team decided
to continue with catatonia as the working diagnosis and
started administering ECT after detailed discussion with
the family and taking informed consent. When no
significant change in symptoms was observed,
neuropsychiatric consultation was sought. On
neuropsychiatric evaluation, patient was found to have
vertical supranuclear gaze palsy, with rigidity and
bradykinesia in the extremities, and dystonia/
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anteroflexion of the neck. Speech was also dysarthric
and spastic. On gait examination, he had small
shuffling steps with reduced arm swing bilaterally and a
stooped posture. On cognitive examination, patient was
not testable as he was not responding to any questions
or instructions. Based on the history, examination, and
work up a diagnosis of possible PSP was made using
the NINDS-SPSP criteria. MRI brain did not show the
typical mid brain tegmentum atrophy or the humming
bird sign seen in some typical cases of PSP.
DISCUSSION
This case illustrates diagnostic confusion in
differentiating neurodegenerative dementias especially
those that have motor and/or psychiatric symptoms
with other psychiatric conditions such as catatonia.
Initial motoric immobility, profound negativism,
echolalia, reduced eating, and incontinence presenting
in psychiatric ward led to working diagnosis of
catatonia. Some initial Improvement from ECT and
absence of any other major pathology on MRI added to
further confusion. But later ophthalmologic symptoms,
neck dystonia, parkinsonism and cognitive impairment
favored the diagnosis of PSP. Although typical cases of
PSP present with axial rigidity, gait instability, and falls
followed by worsening parkinsonism, dysarthria,
dysphagia, and eye movement abnormalities6, there
may be other modes of onset such as non specific
dizziness, generalized motor slowing, and personality
changes. Some other variants of PSP are also
recognized, which may present differently than typical
PSP, such as progressive supranuclear palsy-pure
akinesia with gait freezing (PSP-PAGF), progressive
supranuclear palsy-corticobasal syndrome (PSP-CBS),
progressive supranuclear palsy-behavioral variant of
frontotemporal dementia (PSP-bvFTD) and progressive
supranuclear palsy-progressive non-fluent aphasia
(PSP-PNFA).7 Many times diagnosis of PSP is difficult to
make and other conditions such as multiple system
atrophy, frontal variant of PSP, or FTD may also be
considered in such complicated cases. Absence of
marked atrophy of mid brain or signal abnormalities in
basal ganglia or pons on MRI, as in this case, added to
the complexity of diagnosis. Usually MRI findings of PSP
include atrophy of the mid brain, pons, and cerebellum
with signal increase in inferior olives, atrophy of frontal
and/ or temporal lobes, and often humming bird sign
which appears due to rostral mid brain atrophy on mid
sagittal images.8 In this case absence of marked frontal
atrophy and absence of dysautonomia including
bladder and bowel incontinence early in the course of
the disease made FTD and MSA less likely. Parkinson’s
disease typically presents with features of parkinsonism
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Conclusion:

including appendicular rigidity and rest tremor and may
have focal dystonias at times, and typically responds
well to levodopa. The neurochemistry of PCP is not well
understood. Various theories have implicated
alterations in dopamine, serotonin, acetylcholine and
norepinephrine pathways. Treatment is symptomatic
with L-dopa, dopamine agonists such as bromocriptine
and methysergide, benztropine and amitriptyline in
various combinations with varying degree of success.
Unfortunately, there is no curative treatment available.
4
Pathologically, PSP is characterized by the
accumulation of tau protein and neuropil threads,
mainly in the pallidum, subthalamic nucleus, red
nucleus, substantia nigra, pontine tegmentum,
striatum, oculomotor nucleus, medulla, and dentate
nucleus.7 While PSP is a relatively rare syndrome,
affecting less than 1% of the geriatric population, this
case illustrates the importance of a thorough history,
neurological exam, and neuropsychiatric findings to
differentiate such cases from other neurological
psychiatric conditions such as catatonia.
Not being able to find the correct diagnosis and non
responsiveness to various psychiatric treatment
modalities including to benzodiazepines and ECT added
to family’s distress. Although the prognosis of PSP is
limited, making correct diagnosis, educating the family,
and providing symptomatic treatment may help
manage more effectively as in this case. The family was
from a remote area in Sindh and went back to the
village with follow up scheduled in 3-6 months.

There may be some overlap and confusion between
some psychiatric and neuropsychiatric symptoms,
especially less common neurodegenerative conditions
with motor and/or psychiatric presentations, which if
not appreciated may lead to delayed diagnosis and
mismanagement. It is important to keep PSP on the list
of differential diagnoses with other organic diseases
causing catatonia and depression.
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